Revelation Biosciences FY2023 net loss narrows to $0.1M; cash $12.0M through 2024

REVELATION BIOSCIENCES, INC.

Year-end cash $12.0M vs $5.3M; company believes sufficient to fund operations through 2024.
Net loss for FY2023 $0.1M (EPS -$0.53) vs $10.8M loss ($149.20 EPS) in 2022, due to $8.3M warrant liability gain.
Q4 2023 net loss $2.2M ($8.33 EPS) vs $1.2M loss ($15.61 EPS) in Q4 2022; operating cash burn $2.0M.
Completed $6.2M public offering; began Phase 1 study of Gemini; presented positive preclinical AKI data.
Net cash used in operations for FY2023 was $7.3M, down from $11.2M in 2022.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

REVELATION BIOSCIENCES, INC. reported twelve months ended December 31, 2023 results: net income net loss of $0.1 million, EPS $0.53 basic and diluted net loss per share.

Period: twelve months ended December 31, 2023
Net income: net loss of $0.1 million
EPS: $0.53 basic and diluted net loss per share
Result: reported results

Exact text from the filing

Revelation’s net loss for the three and twelve months ended December 31, 2023 was $2.2 million and $0.1 million, or $8.33 and $0.53 basic and diluted net loss per share, respectively

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

REVELATION BIOSCIENCES, INC. reported three months ended December 31, 2023 results: net income net loss of $2.2 million, EPS $8.33 basic and diluted net loss per share.

Period: three months ended December 31, 2023
Net income: net loss of $2.2 million
EPS: $8.33 basic and diluted net loss per share
Result: reported results

Exact text from the filing

Revelation’s net loss for the three and twelve months ended December 31, 2023 was $2.2 million and $0.1 million, or $8.33 and $0.53 basic and diluted net loss per share, respectively

View on SEC.gov

326 earnings releases filed in the last 30 days. Browse all earnings releases →

REVELATION BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-24-035376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.